Page 6 - Cell Genesys News Today : Breaking News, Live Updates & Top Stories | Vimarsana

“It’s been only 11 months since the coronavirus pandemic broke out and we already have vaccines being distributed around the world. There is no doubt, this has been one of the biomed sector’s finest hours,” said Aya Jakobovits, a serial entrepreneur and investor in the life science sector in an interview to CTech. “It really showcased the depth of new technology and its ability to integrate into solutions quickly and effectively. All of a sudden there is a new interest in infectious diseases that arises from the understanding that there will be more pandemics in the future.”
 Jakobovits spoke to CTech from Los Angeles, but is a Silicon Valley veteran, having arrived on the West Coast of the U.S. in 1982 for her postdoctoral studies, after completing her first degrees in Israel at Hebrew University and Ph.D. the Weizmann Institute of Science. Since then, she founded and held senior management positions at a series of life science companies, including Adicet Bio, ....

United States , San Francisco , Adicet Bio , Aya Jakobovits , Los Angeles , Jim Koshland , Oded Hermoni , Aya Jakobovitz , Yeda Research , Conversa Health , Weizmann Institute Of Science , Connie Health , Jewish Federation , Israel At Hebrew University , Development Co , Technology Development Corporation , Silicon Valley , West Coast , Hebrew University , Weizmann Institute , Kite Pharma , Cell Genesys , Development Corporation , Visby Medical , Israeli Tech , Managing Partner ,